FILE FILE: Teva Pharmaceutical Industries logo appears during a news conference by its CEO, Kare Schultz, to discuss the company's 2019 views in Tel Aviv, Israel 19 February, 2019. REUTERS / Amir Cohen
CLEVELAND (Reuters) – Executives from a number of major healthcare companies and general state solicitors were proceeding towards expected to deal with multi-billion dollars to resolve the turbulent litigation over the U opioid epidemic. lawyer complained Friday. t
“I think we can make progress,” said Peter Weinberger, a relationship with the barrister in litigation, in response to a reporter asking if it was possible to deal on Friday.
Weinberger said District Judge Dan Polster was approaching health care executives and lawyers of state solicitors and other lawyers who were privately bundled into separate rooms in Cleveland's federal courthouse.
Polster asked executives from McKesson Corp (MCK.N), Teva Pharmaceutical Industries Inc () tTEVA.TA), Cardinal Health Inc ( tCAH.N) and AmerisourceBergen Corp (ABC.N) his court to try to deal with before a significant trial begins on a Monday.
Polster is overseeing the thousands of legal cases arising from the opioid addiction crisis which allows the companies to fuel a health crisis responsible for around 400,000 deaths in 1999 to 2017, according to government statistics.
Tom Hals wrote in Wilmington, Delaware; Edited by Giles Elgood
(TTTranslate tags) USA (t) USA (t) OFFICES (t) LIGITAL (t) SETTLEMENT (t) Medical Equipment: Supplies and Distribution (TRBC) (t) Israel News (t) Company (t) Health / Medicine (t) Judicial Processes / Court Cases / Court Decisions (t) Drug Retailers (TRBC) (t) Middle East (TBC) Healthcare (t) USA